Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

The New England Journal of Medicine
G JourdainPerinatal HIV Prevention Trial Group

Abstract

A single intrapartum dose of nevirapine for the prevention of mother-to-child transmission of human immunodeficiency virus (HIV) leads to the selection of resistance mutations. Whether there are clinically significant consequences in mothers who are subsequently treated with a nevirapine-containing regimen is unknown. We randomly assigned 1844 women in Thailand who received zidovudine during the third trimester of pregnancy to receive intrapartum nevirapine or placebo. In the postpartum period, 269 of the women with a CD4 count below 250 cells per cubic millimeter began a nevirapine-containing antiretroviral regimen. Plasma samples were obtained 10 days post partum and analyzed for resistance mutations. Plasma HIV type 1 (HIV-1) RNA was measured before the initiation of therapy and three and six months thereafter. After six months of therapy, the HIV-1 RNA level was less than 50 copies per milliliter in 49 percent of the women who had received intrapartum nevirapine, as compared with 68 percent of the women who had not received intrapartum nevirapine (P=0.03). Resistance mutations to nonnucleoside reverse-transcriptase inhibitors were detectable in blood samples obtained 10 days post partum from 32 percent of the women who had ...Continue Reading

References

Jun 24, 2003·AIDS·Bradley W KoselFrancesca T Aweeka
Aug 5, 2003·Antiviral Research·Robert J Visalli, Marja van Zeijl
Jan 27, 2004·Antimicrobial Agents and Chemotherapy·Edward P AcostaUNKNOWN Pediatric AIDS Clinical Trials Group 386 Protocol Team,
Jul 13, 2004·The New England Journal of Medicine·Marc LallemantUNKNOWN Perinatal HIV Prevention Trial (Thailand) Investigators
Jun 16, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Amphan ChalermchockcharoenkitJordan W Tappero

❮ Previous
Next ❯

Citations

Jul 13, 2006·Archives of Pharmacal Research·Rafik SamuelByungse Suh
Apr 13, 2006·Current HIV/AIDS Reports·Mary A Vogler
Aug 19, 2005·Current Infectious Disease Reports·Matthew F Chersich, Glenda E Gray
Nov 15, 2007·Current Infectious Disease Reports·Katherine Luzuriaga
Sep 29, 2012·Clinical Pharmacokinetics·Kajal BuckoreelallJennifer R King
Jul 4, 2008·Chemical Research in Toxicology·Alexandra M M AntunesM Matilde Marques
Nov 5, 2004·The New England Journal of Medicine·Christian Herzmann, Heiko Karcher
Jul 13, 2004·The New England Journal of Medicine·Hoosen Coovadia
Jul 13, 2004·The New England Journal of Medicine·Marc LallemantUNKNOWN Perinatal HIV Prevention Trial (Thailand) Investigators
Jan 12, 2007·The New England Journal of Medicine·Shahin LockmanMax Essex
Oct 15, 2010·The New England Journal of Medicine·Shahin LockmanUNKNOWN OCTANE A5208 Study Team
Oct 15, 2010·The New England Journal of Medicine·Paul PalumboAvy Violari
Dec 13, 2005·Sexual Health·Valerio TozziPasquale Narciso
Jul 12, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R ColebundersM Sande
Dec 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lisa A SpacekThomas C Quinn
Jan 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Heather J RibaudoUNKNOWN Adult AIDS Clinical Trials Group Study
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Charles B HolmesRochelle P Walensky
Dec 5, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul ThistleMichael Silverman
Jan 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patrick A CoffieFrançois Dabis
Jan 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Glenda E Gray
Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tim R CresseyUNKNOWN Paediatric European Network for Treatment of AIDS II Study Group
Jan 13, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ashraf CoovadiaLouise Kuhn
Jan 13, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John W Mellors, Jeremy Y Chow
Nov 18, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Renaud BecquetFrançois Dabis
Feb 18, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marc LallemantUNKNOWN PHPT-4 Study Team
Apr 10, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gonzague JourdainUNKNOWN Program for HIV Prevention and Treatment (PHPT) Study Group
Apr 14, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark A MicekLisa M Frenkel
Jul 24, 2010·The Journal of Infectious Diseases·Sara Gianella, Douglas D Richman
Jun 10, 2005·AIDS Research and Human Retroviruses·Dana JonesSusan H Eshleman
Sep 23, 2006·AIDS Research and Human Retroviruses·Lisa M FrenkelRobert W Coombs
Mar 29, 2008·AIDS Research and Human Retroviruses·Jessica D ChurchSusan H Eshleman
Oct 3, 2009·AIDS Research and Human Retroviruses·Sharon ShalekoffCaroline T Tiemessen
Jan 19, 2011·AIDS Research and Human Retroviruses·Deborah PersaudUNKNOWN Ethiopian Swen Study Team
Dec 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Russell B Van DykeUNKNOWN IMPAACT P1032 Protocol Team
May 30, 2007·International Journal of Epidemiology·Elise ArrivéUNKNOWN Ghent Group on HIV in Women and Children

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.